Quidel Corp.

NASDAQ:QDEL   3:59:54 PM EDT
141.41
-1.54 (-1.08%)
Products

FDA Says Quidel Recalls Lyra Sars-Cov-2 Assay (M120)

Published: 07/07/2021 19:47 GMT
Quidel Corp. (QDEL) - FDA Says Quidel Recalls Lyra Sars-cov-2 Assay (m120) Due to Risk of False Negative Results.
FDA Says Identified Quidel's Recall of Lyra Sars-cov-2 Assay As a Class I Recall.
FDA Says Quidel Received Five Complaints About the Lyra Sars-cov-2 Assay (m120), However, There Have Been No Reports of Injuries Or Death From Issue.
FDA Says 18,385 Devices of Lyra Sars-cov-2 Assay (m120) Have Been Recalled in U.S.